RAD51 and non-small cell lung carcinoma: Consistently, inhibition of RAD51 significantly increased the sensitivity of A549 cells to (−)-Guaiol which supplies an alternative application of (−)-Guaiol in combination with RAD51 targeted small molecules in NSCLC treatments.